Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZQA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,358
Award facts
- Contract value 100% obligated
- $35,358.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,358.16 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 9, 2026, for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL pharmaceutical product. The order, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award issued to the prime contractor's Corporate Office division located in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical commodities to military healthcare programs globally.
AmerSourceBergen Drug Corp maintains a substantial federal contract portfolio focused on delivering prescription medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities and other federal health systems. The firm fixed-price structure and rapid three-day completion window indicate this is a routine pharmaceutical replenishment order to support ongoing military healthcare operations. The award demonstrates the contractor's continued capability to fulfill federal procurement requirements for critical pharmaceutical supplies through its established relationship with DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F4ZQA?
SPE2DR26F4ZQA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F4ZQA worth?
The government has obligated $35,358 on SPE2DR26F4ZQA.
Is contract SPE2DR26F4ZQA an order under another contract?
Yes. SPE2DR26F4ZQA is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZQA competed?
The extent of competition for SPE2DR26F4ZQA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award